Effect of Primary Dysmenorrhea on Muscle Activity in Young Adult Females

NCT ID: NCT07095725

Last Updated: 2025-08-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

72 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-01

Study Completion Date

2025-11-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate the effect of primary dysmenorrhea on the activity of the abdominal and back muscles in young adult females.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PD is highly prevalent in females, which directly influences their quality of life, physical function and performance. A study conducted in Palestine has shown that over half of university students with dysmenorrhea tend to skip university lectures due to painful menses.

PD is commonly associated with visceral pain and various musculoskeletal symptoms, including abdominal and back pain (Yacubovich et al., 2019). This can reduce the maximum voluntary contraction of the affected muscles, compromising their ability to provide adequate support and stability (Merkle et al., 2020). Persistent pain can disrupt postural stability and balance, raising the risk of injury by compromising stability and muscle function.

Research highlights the impact of primary dysmenorrhea (PD) on muscle function, particularly in the abdominal and back muscles, contributing to pain and reduced stability. Oladosu et al. (2018) found that abdominal muscle activity precedes menstrual pain, suggesting a neuromuscular link. Similarly, Karakus et al. (2022) and Álvarez et al. (2024) reported altered activation and reduced endurance in stabilizing muscles, including the transversus abdominis, obliques, and lumbar multifidus, with muscle thinning that may impair spinal stability. These studies emphasize PD's effect on muscle function, but further research is needed to explore variations across severities and guide effective treatments.

When these weakened muscles because of dysmenorrhea are subjected to increased or sudden activity during daily living tasks, such as lifting, bending, or other physical exertions, the risk of injury to the structures they are designed to protect is significantly heightened (Escamilla et al., 2010; Polat et al., 2022).

However, to the best of the authors' knowledge, no research has yet explored the relationship of abdominal and back muscle activity patterns to PD and their variations across different severities of dysmenorrhea, which directly contributes to females' quality of life.

Understanding this association could have significant clinical implications and contribute to new knowledge that helps physical therapists determine the need for custom-designed prevention and treatment programs for females with PD. By raising awareness of the potential musculoskeletal risks associated with PD, this study emphasizes the importance of minimizing strenuous activities during menstruation to reduce muscle strain or injury, ultimately enhancing overall health and well-being during this period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Dysmenorrhea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A: Mild dysmenorrhea

Females with mild PD, scoring (1-4) on the WaLLID scale.

Record EMG maximum amplitude from rectus abdominis, erector spinae L3 level

Intervention Type DIAGNOSTIC_TEST

EMG Electrode Placement and Muscle Assessment:

Electrodes for the rectus abdominis were placed longitudinally at the umbilical level. For the erector spinae, L3 was located using a line between the posterior superior iliac crests, and electrodes were placed \~3 cm lateral to the L3 spinous process.

Assessment:

Rectus Abdominis: In the crook-lying position, participants performed a slow curl-up (\~35-40°), holding for 10 seconds.

Erector Spinae: In the prone position with a 10-cm pad under the abdomen, participants lifted the upper body with neutral cervical alignment for 10 seconds.

Each test was repeated three times with 2-minute rest intervals.

Group B: Moderate dysmenorrhea

Females with moderate PD, scoring (5-7) on the WaLLID scale.

Record EMG maximum amplitude from rectus abdominis, erector spinae L3 level

Intervention Type DIAGNOSTIC_TEST

EMG Electrode Placement and Muscle Assessment:

Electrodes for the rectus abdominis were placed longitudinally at the umbilical level. For the erector spinae, L3 was located using a line between the posterior superior iliac crests, and electrodes were placed \~3 cm lateral to the L3 spinous process.

Assessment:

Rectus Abdominis: In the crook-lying position, participants performed a slow curl-up (\~35-40°), holding for 10 seconds.

Erector Spinae: In the prone position with a 10-cm pad under the abdomen, participants lifted the upper body with neutral cervical alignment for 10 seconds.

Each test was repeated three times with 2-minute rest intervals.

Group C: Severe dysmenorhhea

Females with severe PD, scoring (8-12) on the WaLLID scale.

Record EMG maximum amplitude from rectus abdominis, erector spinae L3 level

Intervention Type DIAGNOSTIC_TEST

EMG Electrode Placement and Muscle Assessment:

Electrodes for the rectus abdominis were placed longitudinally at the umbilical level. For the erector spinae, L3 was located using a line between the posterior superior iliac crests, and electrodes were placed \~3 cm lateral to the L3 spinous process.

Assessment:

Rectus Abdominis: In the crook-lying position, participants performed a slow curl-up (\~35-40°), holding for 10 seconds.

Erector Spinae: In the prone position with a 10-cm pad under the abdomen, participants lifted the upper body with neutral cervical alignment for 10 seconds.

Each test was repeated three times with 2-minute rest intervals.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Record EMG maximum amplitude from rectus abdominis, erector spinae L3 level

EMG Electrode Placement and Muscle Assessment:

Electrodes for the rectus abdominis were placed longitudinally at the umbilical level. For the erector spinae, L3 was located using a line between the posterior superior iliac crests, and electrodes were placed \~3 cm lateral to the L3 spinous process.

Assessment:

Rectus Abdominis: In the crook-lying position, participants performed a slow curl-up (\~35-40°), holding for 10 seconds.

Erector Spinae: In the prone position with a 10-cm pad under the abdomen, participants lifted the upper body with neutral cervical alignment for 10 seconds.

Each test was repeated three times with 2-minute rest intervals.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All females clinically diagnosed with PD, as confirmed and referred by a gynecologist.
* Age ranges from 18 to 25 years.
* BMI ranges from 20 to 25 kg/m2 .
* Onset of menstrual pain 6-24 months after menarche.
* Having a regular menstrual cycle (28 ± 7 days with no intermittent bleeding).
* Their PD symptoms will be determined according to the WaLLID questionnaire and will be classified into mild PD (1-4), moderate PD (5-7), severe PD (8-12).
* All participants are virgins.

Exclusion Criteria

* Menstrual irregularity.
* Use of antidepressant or steroid drugs.
* Secondary dysmenorrhea.
* Musculoskeletal problems in the abdominal region, pelvic region, or spine.
* Surgical history involving the abdominal region, pelvic region, or spine in the last year.
* Any psychiatric or gynecological problems.
Minimum Eligible Age

18 Years

Maximum Eligible Age

25 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mahenour Esmail Taha

Teaching Assistant

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mahenour Esmail Shendy, Bachelor of Physical Therapy

Role: PRINCIPAL_INVESTIGATOR

Teaching Assistant of Physical Therapy For Women's Health- Misr University for Science and Technology

Doaa Ahmed Osman, Assistant Professor

Role: STUDY_CHAIR

Physical Therapy for Women's Health - Faculty of Physical Therapy- Cairo University

Manal Ahmed Elshafei, Lecturer

Role: STUDY_DIRECTOR

Physical Therapy for Women's Health - Faculty of Physical Therapy- Cairo University

Ihab Kamal Younis, lecturer

Role: STUDY_DIRECTOR

Obstetrics and Gynecology department - Faculty of Medicine Misr university for science and technology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Misr University for Science and Technology

Giza, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mahenour Esmail Shendy, Bachelor of Physical Therapy

Role: CONTACT

01112129932

Abdelrahman Salah Sawan, Bachelor of Physical Therapy

Role: CONTACT

01144047770

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mahenour Esmail Shendy, Bachelors of Physical Therapy

Role: primary

01112129932

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC\012\005884

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.